These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 1668604)

  • 1. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 312():86-103. PubMed ID: 1663336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
    Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y
    Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle.
    Nakayama K; Kurihara J; Miyajima Y; Ishii K; Kato H
    Arzneimittelforschung; 1985; 35(4):687-93. PubMed ID: 4015735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta.
    Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
    Jpn J Pharmacol; 1991 Nov; 57(3):337-48. PubMed ID: 1667534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
    Nakaya H; Hattori Y; Nakao Y; Kanno M
    Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium.
    Boyd RA; Giacomini JC; Wong FM; Nelson WL; Giacomini KM
    J Pharmacol Exp Ther; 1987 Oct; 243(1):118-25. PubMed ID: 2822893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
    Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
    J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
    Hattori Y; Nakaya H; Tohse N; Kanno M
    J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.
    Tanaka H; Masumiya H; Sekine T; Sijuku T; Sugahara M; Taniguchi H; Terada M; Saito W; Shigenobu K
    Gen Pharmacol; 1996 Apr; 27(3):451-4. PubMed ID: 8723524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
    Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative.
    Masuda Y; Takeguchi M; Arakawa C; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1990; 304():247-64. PubMed ID: 2241414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.